Market Research Logo

Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022

Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022

About Diffuse Large B-Cell Lymphoma

DLBCL is a cancer of B-lymphocytes. It is the most common type of NHL among adults. It is an aggressive (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system.

Technavio’s analysts forecast the Global DLBCL Therapeutics Market to grow at a CAGR of 7.64% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the DLBCL therapeutics market. To calculate the market size, the report considers the revenue generated from the application of DLBCL therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, DLBCL therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • F. Hoffmann-La Roche
  • Merck Sharp & Dohme
  • Novartis
  • Pfizer
  • Spectrum Pharmaceuticals
Market driver
  • Increasing incidences of DLBCL
  • For a full, detailed list, view our report
Market challenge
  • High cost of treatment
  • For a full, detailed list, view our report
Market trend
  • Technological advances
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global DLBCL therapeutics market: F. Hoffmann-La Roche, Merck Sharp & Dohme, Novartis, Pfizer, and Spectrum Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the technological advances. Companies are focusing on developing new technologies and innovative therapies which can overcome current challenges in the treatment of various cancers, including DLBCL.”

According to the report, one driver influencing this market is the increasing incidences of DLBCL. DLBCL is a fast-growing and common type of NHL among adults. The incidence of DLBCL is increasing globally and can be fatal if untreated.

Further, the report states that one challenge affecting this market is the high cost of treatment. The cost of chemotherapy, laboratory tests, and oral medications for the treatment of DLBCL are high which is a major challenge for the growth of the market.

Companies Mentioned

F. Hoffmann-La Roche
Merck Sharp & Dohme
Novartis
Pfizer
Spectrum Pharmaceuticals

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global NHL therapeutics market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global DLBCL therapeutics market - Market size and forecast 2017-2022 ($ mn)
      • Table Global DLBCL therapeutics market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline
    • Table Pipeline landscape by development phase 2017-2018
    • Table Late-stage pipeline molecules for treatment of DLBCL 2017-2018
  • Market segmentation by product
    • Segmentation by product
      • Table Global DLBCL therapeutics market by product - Market share 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • Small molecules - Market size and forecast 2017- 2022
      • Table Global DLBCL therapeutics market by small molecules - Market size and forecast 2017- 2022 ($ mn)
      • Table Global DLBCL therapeutics market by small molecules - Year-over-year growth 2018- 2022 (%)
    • Biologics - Market size and forecast 2017-2022
      • Table Global DLBCL therapeutics market by biologics - Market size and forecast 2017-2022 ($ mn)
      • Table Global DLBCL therapeutics market by biologics - Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global DLBCL therapeutics market - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table DLBCL therapeutics market in Americas - Market size and forecast 2017-2022 ($ mn)
      • Table DLBCL therapeutics market in Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table DLBCL therapeutics market in EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table DLBCL therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table DLBCL therapeutics market in APAC - Market size and forecast 2017-2022 ($ mn)
      • Table DLBCL therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Technological advances
    • Increasing patient support programs
    • Strategic alliances
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche - Overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
      • Table F. Hoffmann-La Roche - Key customers
    • Merck Sharp & Dohme
      • Table Merck Sharp & Dohme - Overview
      • Table Merck Sharp & Dohme - Business segments
      • Table Merck Sharp & Dohme - Organizational developments
      • Table Merck Sharp & Dohme - Geographic focus
      • Table Merck Sharp & Dohme - Segment focus
      • Table Merck Sharp & Dohme - Key offerings
      • Table Merck Sharp & Dohme - Key customers
    • Novartis
      • Table Novartis - Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Pfizer
      • Table Pfizer - Overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
      • Table Pfizer - Key customers
    • Spectrum Pharmaceuticals
      • Table Spectrum Pharmaceuticals: Overview
      • Table Spectrum Pharmaceuticals - Business segments
      • Table Spectrum Pharmaceuticals - Organizational developments
      • Table Spectrum Pharmaceuticals - Geographic focus
      • Table Spectrum Pharmaceuticals - Key offerings
      • Table Spectrum Pharmaceuticals - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report